John F. Hardesty MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri.
Mo Med. 2022 Jan-Feb;119(1):42-48.
As rates of global obesity and diabetes increase, diabetic retinopathy continues to grow as a frequent cause of visual impairment. Despite tremendous recent strides in therapy, a significant fraction of patients remain poorly responsive to modern interventions. Adjunctive therapy in such settings could be widely beneficial. A growing body of evidence suggests that weight reduction strategies for obesity-related diabetes have the potential to serve as important supplements to modern ophthalmic care for preservation of vision.
随着全球肥胖和糖尿病发病率的上升,糖尿病视网膜病变作为一种常见的致盲原因持续增加。尽管最近在治疗方面取得了巨大进展,但仍有相当一部分患者对现代干预措施反应不佳。在这种情况下,辅助治疗可能会广泛受益。越来越多的证据表明,针对肥胖相关糖尿病的减肥策略有可能成为现代眼科护理的重要补充,以保护视力。